News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Maternal Response to Zika Damages Mouse Fetuses
Catherine Offord | Jan 5, 2018
Signaling pathways triggered by the mother’s immune system may cause complications during fetal development.
Study: Facial Cues Indicate Sickness
Diana Kwon | Jan 4, 2018
Pale skin and hanging eyelids are tell-tale signs of apparent illness.
Antiviral Immunotherapy Comes of Age
Lucas Laursen | Dec 4, 2017
T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections.
Immune System Targets Diverse Viruses Using the Same Small Peptide
Catherine Offord | Dec 1, 2017
A single receptor on natural killer cells recognizes an amino acid sequence conserved across Zika, dengue, and related pathogens.
Study: Autism Linked with Different Reactions to Chemical Signals
Shawna Williams | Nov 27, 2017
Responses to compounds in human sweat may help explain why people with autism spectrum disorder tend to struggle with social cues.
European Research Council Founder, Molecular Biologist Dies
Catherine Offord | Nov 20, 2017
Fotis Kafatos, a Greek researcher famous for his work on malaria, has died at age 77.
Researchers Build a Cancer Immunotherapy Without Immune Cells
Abby Olena | Nov 13, 2017
A team has engineered two stem cell lines into “synthetic T cells” that destroy breast cancer cells in vitro.
Three Dartmouth Scientists Being Investigated for Sexual Misconduct
Catherine Offord | Oct 31, 2017
The professors, all faculty members in the college’s department of psychology and brain sciences, have been placed on paid leave.
FDA Approves Second CAR T-Cell Therapy
Ashley P. Taylor | Oct 19, 2017
The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas.
Compound Found in Red Wine Boosts Immune Cell Function
Catherine Offord | Oct 16, 2017
At low doses, resveratrol enhanced human T-cell activity in vitro, while at high doses it interfered with cell signaling.